| Features: |
| Cysteamine is a prescription drug, approved for treating cystinosis -it is not sold over-the-counter as a dietary supplement. -In contrast, related compounds like N-acetylcysteine (NAC) and pantethine are widely available supplements and can indirectly support cysteamine-related pathways (e.g., antioxidant defenses and CoA metabolism). -Pantethine: Precursor to CoA, which breaks down into cysteamine -Pantothenic Acid (Vitamin B5): Required for CoA synthesis -Cysteamine increases glutathione (GSH) levels, reducing oxidative stress, a major contributor to AD pathology. -Some studies suggest that cysteamine increases brain-derived neurotrophic factor (BDNF) levels -Cysteamine has been observed to reduce amyloid plaque burden in animal models of AD. |
| Source: |
| Type: |
| custom |
| 4332- | Cyste, | Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases |
| - | in-vivo, | Park, | NA | - | in-vivo, | HD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:369 Target#:767 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid